摘要
目的 构建人程序性死亡受体配体1(programmed cell death ligand 1,PD-L1)免疫球蛋白可变区(immunoglobulin variable region,IgV)结构域基因酵母双杂交重组诱饵质粒,检测其在酵母中的表达情况,检测PD-L1 IgV蛋白细胞毒性和自我激活,以及PD-L1 IgV与人硫氧还蛋白(human thioredoxin,hTrx)之间的相互作用情况。方法 利用生物信息学方法对人PD-L1进行分析,并根据NCBI GenBank数据库中登录的PD-L1基因编码区序列设计扩增PD-L1 IgV结构域的引物,以pENTER-PD-L1质粒为模板进行PCR扩增,克隆至酵母双杂交诱饵载体pGBKT7。将鉴定正确的重组诱饵质粒及pGBKT7空载体分别转化至Y2HGold酵母细胞,PCR及Western blot法检测PD-L1 IgV基因及蛋白的表达;同时检测PD-L1 IgV蛋白毒性及自我激活效应,并采用滴板法检测诱饵蛋白PD-L1 IgV与hTrx相互作用情况。结果 PD-L1的生物信息学分析结果与相关报道一致;成功构建了重组诱饵质粒pGBKT7-PD-L1 IgV,并获得Y2HGold阳性克隆子,PD-L1 IgV能在其中稳定表达。空载体pGBKT7、重组诱饵质粒pGBKT7-PD-L1 IgV在SD/-Trp、SD/-Trp/X-α-Gal平板上生长良好,菌落大小、数量一致,呈白色,在SD/-Trp/X-α-Gal/AbA平板上两者均不生长,表明PD-L1 IgV蛋白对酵母无毒性且无自我激活效应;滴板法试验结果显示,所有实验组在SD/-Trp/-Leu平板上生长良好,仅阳性对照组可在SD/-Trp/-Leu/X-α-Gal/AbA平板上生长且呈蓝色,表明诱饵蛋白PD-L1 IgV、hTrx不存在自我激活现象,且两者之间也不存在相互作用。结论 成功构建了重组人PD-L1 IgV酵母双杂交诱饵质粒,PD-L1 IgV蛋白对酵母细胞无毒性且无自我激活效应,且与hTrx之间无相互作用。后续可利用hTrx构建肽适体文库,从中筛选可与PD-L1 IgV特异结合的肽适体。
Objective To construct a yeast two-hybrid recombinant bait plasmid of human programmed cell death ligand 1(PD-L1)immunoglobulin variable region(IgV)domain gene,detect its expression in yeast and detect the cytotoxicity and self-activation of PD-L1 IgV protein as well as the interaction between PD-L1 IgV and human thioredoxin(hTrx).Methods Human PD-L1 was analyzed by bioinformatics method,and primers were designed to amplify PD-L1 IgV domain based on the coding region of PD-L1 gene registered in NCBI GenBank database.PCR amplification was carried out with pENTERPD-L1 plasmid as template,and then cloned into yeast two-hybrid bait vector pGBKT7.The recombinant bait plasmid and pGBKT7 empty vector were transformed into Y2HGold yeast cells respectively,and the PD-L1 IgV gene and its expression were detected by PCR and Western blot;Meanwhile,the protein toxicity and self-activation of PD-L1 IgV were detected,and the interaction between PD-L1 IgV and hTrx was detected by drip plate method.Results The bioinformatics analysis results of PD-L1 were consistent with related reports.The recombinant bait plasmid pGBKT7-PD-L1 IgV was correctly constructed,and Y2HGold positive clone was obtained,in which PD-L1 IgV was stably expressed.The empty vector pGBKT7 and recombinant bait plasmid pGBKT7-PD-L1 IgV grew well on SD/-Trp and SD/-Trp/X-α-Gal plates with the same colony size and number and white colony,but they did not grow on SD/-Trp/X-α-Gal/AbA plates,which indicated that PD-L1 IgV protein had no toxicity and no self-activation effect on yeast.The results of drip plates test showed that all experimental groups grew well on SD/-Trp/-Leu plate,while only positive control group grew on SD/-Trp/-Leu/X-α-Gal/AbA plate and showed blue color,which indicated that bait protein PD-L1 IgV and hTrx did not self-activate,and there was no interaction between them.Conclusion Recombinant human PD-L1 IgV bait plasmid was successfully constructed.PD-L1 IgV protein showed no toxicity and self-activation effect on yeast cells,and there was no interaction between PD-L1 IgV and hTrx.Subsequently,hTrx can be used to construct a peptide aptamer library,from which peptide aptamers that specifically bind to PD-L1 IgV can be screened.
作者
刘鹏
彭岳
LIU Peng;PENG Yue(Center for Medical Innovation,School of Basic Medical Science,Guangxi University of Chinese Medicine,Nanning,530200,Guangxi Zhuang Autonomous Region,China)
出处
《中国生物制品学杂志》
CAS
CSCD
2024年第1期8-16,共9页
Chinese Journal of Biologicals
基金
国家自然科学基金(81902764)。
关键词
程序性死亡受体配体1
免疫球蛋白可变区
诱饵质粒
酵母双杂交系统
自我激活
肿瘤免疫治疗
Programmed cell death ligand 1(PD-LI)
Immunoglobulin variable region(IgV)
Bait plasmid
Yeast two-hybrid system
Self-activation
Tumor immunotherapy